L
Lineage Cell Therapeutics Inc
F:BT3
Lineage Cell Therapeutics Inc
F:BT3
Price:
1.062
EUR
-0.93%
Market Closed
Market Cap:
€200.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lineage Cell Therapeutics Inc
F:BT3
|
US |
|
Ur-Energy Inc
F:U9T
|
US |
|
C
|
Clarity Pharmaceuticals Ltd
OTC:CLRPF
|
AU |
|
A
|
Azimut Holding SpA
OTC:AZIHF
|
IT |
|
S
|
Snam SpA
OTC:SNMRY
|
IT |
|
W
|
Wilmar International Ltd
OTC:WLMIY
|
SG |
Multiples-Based Value
The Multiples-Based Value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is hidden EUR. Compared with the current market price of 1.062 EUR, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BT3 Multiples-Based Value
LOCKED
